Discontinued — last reported Q3 '24

Products & Services · Additions

Grant revenue — Additions

Year-over-year, this metric grew by 300.0%, from $2.00M to $8.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2020
Last reportedQ3 2024Nov 7, 2024

How to read this metric

Higher additions signal strong business development success and continued interest from grant-awarding institutions in the company's technology.

Detailed definition

This represents new grant funding commitments or increases to existing awards recognized during the reporting period. It...

Peer comparison

Comparable to 'new bookings' or 'new contract wins' in service-based or project-based business models.

Metric ID: mrna_segment_grant_revenue_additions

Historical Data

13 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24
Value$8.00M$10.00M$0.00$0.00$0.00$0.00$0.00$0.00$2.00M$0.00$0.00$0.00$8.00M
QoQ Change+25.0%-100.0%-100.0%
YoY Change-100.0%-100.0%+300.0%
Range$0.00$10.00M
CAGR+0.0%
Avg YoY Growth+33.3%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Moderna's grant revenue — additions?
Moderna (MRNA) reported grant revenue — additions of $8.00M in Q3 2024.
How has Moderna's grant revenue — additions changed year-over-year?
Moderna's grant revenue — additions increased by 300.0% year-over-year, from $2.00M to $8.00M.
What does grant revenue — additions mean?
The value of new grant funding secured during the current period.